Committee considers kratom regulation: age limits, labeling and bans on concentrated synthetics
Senators heard testimony on SB 6,287, which would restrict kratom products: require labeling and ingredient disclosure, cap alkaloid concentrations, ban sale of products to anyone under 21 and prohibit harmful adulterants; public health witnesses supported stricter controls while industry groups favored a lighter regulatory approach.
The full story
Senate Bill 6,287 would regulate kratom products by banning certain concentrated or synthetic derivatives, requiring ingredient and alkaloid‑percentage labeling, setting a 21‑and‑older purchase age, and making violations a gross misdemeanor with a private civil right of action and local authority to adopt stricter ordinances.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.